PROVECTUS BIOPHARMACEUTICALS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $0.96 per share as of 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2016-03-30
- 2015-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $0.96.
- 2014-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $0.97.
- 2013-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $0.97.
- 2011-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $0.97.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2015-12-31 | $0.96 10-K · filed 2016-03-30 |
| 2014-12-31 | $0.97 10-K · filed 2015-03-12 |
| 2013-12-31 | $0.97 10-K · filed 2014-03-13 |
| 2011-12-31 | $0.97 10-K · filed 2013-03-14 |